Cargando…
Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products
Recent studies have demonstrated that the plasma soluble receptor for advanced glycation end-products (sRAGE) play a major role in developing macrovascular complications of type 2 diabetes, including peripheral arterial occlusion disease (PAOD). Cilostazol is an antiplatelet, antithrombotic agent, w...
Autores principales: | Liu, Jhih-Syuan, Chuang, Tsung-Ju, Chen, Jui-Hung, Lee, Chien-Hsing, Hsieh, Chang-Hsun, Lin, Tsung-Kun, Hsiao, Fone-Ching, Hung, Yi-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512567/ https://www.ncbi.nlm.nih.gov/pubmed/25666934 http://dx.doi.org/10.1007/s12020-015-0545-6 |
Ejemplares similares
-
Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014) -
Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE/ERK/NF-κB signaling pathways
por: Su, Sheng-Chiang, et al.
Publicado: (2019) -
The Involvement of GAS6 Signaling in the Development of Obesity and Associated Inflammation
por: Wu, Kuo-Sheng, et al.
Publicado: (2015) -
Aggravation of Hypertriglyceridemia and Acute Pancreatitis in a Bipolar Patient Treated with Quetiapine
por: Liou, Li-Syue, et al.
Publicado: (2014) -
High glucose induces human endothelial dysfunction through an Axl-dependent mechanism
por: Lee, Chien-Hsing, et al.
Publicado: (2014)